Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06393608

Epsom Salt Compresses to Relieve Perineal for Postpartum Care: a Clinical Trial

The goal of this clinical trial is to determine if topical application of compresses soaked in 25% magnesium sulfate on painful perineum after birth is effective to alleviate pain.

Researchers will compare this treatment to a placebo, compresses soaked in water. Participants will be invited to use their compresses if needed, for 15 minutes, up to four times a day, during their stay at the hospital after giving birth. They will also have to keep a diary of their usage and of their pain.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Hôpital de Chicoutimi, Chicoutimi, Quebec, Canada

Loading trial locations.

About this study

Background: Despite the high frequency of perineal trauma in obstetrics, management of perineal care and pain is highly variable, relying on very few studies, if any. Treatment of the perineum with compresses soaked in a magnesium sulfate (Epsom salt) solution has not previously been studied but is routinely used in some hospitals in Quebec, Canada. Objectives: This study aims to determine whether compresses soaked in 25% magnesium sulfate in sterile water can alleviate perineal pain in women immediately after childbirth. Population and intervention: Women who have just given birth vaginally and report perineal or vulvar pain of 3/10 or more will be recruited and randomized into an intervention group receiving the treatment (compresses soaked in 25% magnesium sulfate) or a control group receiving a placebo (compresses soaked in water). Methods: This multi-centric, double-blinded randomized clinical trial will be conducted in four hospitals in the province of Quebec, Canada. The investigators plan to recruit a total of 104 participants. Participants will be instructed to apply the compresses on the vulva and perineum for 15 minutes, four times per day, if needed. They will be asked to score their pain before and after using the compresses for the length of their hospital stay, typically between 24 and 48 hours. Secondary outcomes include analgesic use, incidence of complications, participant satisfaction, opinions on feasibility, and any adverse effects caused by the compresses. Discussion: This randomized controlled trial will assess whether the treatment is more effective in relieving pain than the placebo. The study will also determine the safety and feasibility of this method for routine postnatal care. This study could contribute in the long term to the standardization of evidence-based practices for the management of postpartum perineal pain in Canadian hospitals

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Planned hospital stay at the mother-child unit of the Hôpital de Chicoutimi, Hôpital Charles-Le Moyne, or Hôpital Honoré-Mercier
  • Vaginal delivery with or without perineal tear, any degree of tear, including episiotomies
  • Obtaining consent for the study
  • Languages spoken: French, English or both

Exclusion criteria

  • Hemodynamic instability
  • Surgical procedure such as a cesarean section
  • Transfer to another hospital
  • Transfer to another care unit
  • Chronic use of narcotics
  • Inability to complete the logbook
  • Unsigned consent form

Treatment and study plan

Epsom salt

Drug

Epsom salt solution in water, 25% concentration

Other names: magnesium sulfate

Water

Other

Water

Primary outcomes

  1. Pain reduction on the visual and numerical pain scale after each application

    Time frame: 24hours to 48 hours (duration of the stay at the hospital)

    customized visual and numerical pain scale (0-10, 0 being no pain at all and 10 being the worse pain)

Secondary outcomes

  1. other analgesic usage, by filling a medication usage journal

    Time frame: 24hours to 48 hours (duration of the stay at the hospital)

    It includes usually available analgesics, such as acetaminophen, anti-inflammatories, topical analgesics and ice.

  2. Satisfaction, opinions of feasibility through a numerical scale

    Time frame: 24hours to 48 hours (duration of the stay at the hospital)

    Participants will have to fill this part of their diary before they leave the hospital.

  3. Adverse effects, self declared in a journal

    Time frame: 24hours to 48 hours (duration of the stay at the hospital)

    A space in the participant's diary is dedicated for them to declare any benign adverse effects. We don't expect any, since the product is already recognized as safe in literature.

Study contacts

Contact information is provided by the study sponsor or research team.

Antoine Roger, MD, B.sc

CONTACT

[email protected]

450 466-5630

Judith Lajeunesse, MD

CONTACT

Sponsors and collaborators

Lead sponsor

Antoine Roger

Other

Collaborators

  • Hopital Charles Lemoyne
  • Hôpital Brome-Missisquoi-Perkins
  • Hôpital Honoré-Mercier
  • Hôpital de Chicoutimi
  • Université de Sherbrooke

Registry information

Official study title

If the Use of Epsom Salt (magnesium Sulfate) Compresses 25% Effective in Relieving Perineal Pain in Immediate Postpartum Patients?

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
May 1, 2024
Registry last updated
Dec 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.